Finance Committee hears SchoolCare analysis as district faces double‑digit medical trend and high‑cost claims

Concord School District Finance Committee members on Jan. 27 heard a detailed presentation from benefits consultants and SchoolCare about the district’s employee health plan renewal for the 7/25 renewal period and the drivers behind sharply rising costs. Presenters told the committee the district’s total health plan spending is in the low‑to‑mid‑millions annually and that prescription specialty drugs and several very high‑cost medical claims were the principal drivers of the recent increase.

The committee was told that total plan spend for the district in the last full plan year was reported at roughly $13.7 million and that the district ran at a 103% loss ratio for plan year July 2023–June 2024 (compared with an underwriting target of 92%). Consultants said the renewal delivered to the district reflected a 13.4% increase for the existing plan designs; they presented a scenario that would reduce that projected increase to about 9.4% if employees shifted to plan options with higher deductibles (a roughly 4% decrement associated with those plan‑design changes). Committee members were also shown that the most recent six months of experience had improved, with the district running at about an 85% loss ratio during July–December 2024.

Why it matters: presenters said a handful of very costly claims and rising prescription costs — especially specialty and gene‑therapy and GLP‑1 class drugs — are concentrating spending and producing unusually large increases in several districts, including Concord. SchoolCare‑level programs and pharmacy strategies can blunt but not eliminate that pressure, the consultants said.

Presenters and staff outlined current and potential actions the district can take to lower future cost growth while preserving access for employees. Those included plan‑design adjustments that incrementally raise deductibles, stricter formulary controls and prior‑authorization processes, targeted disease‑management and health‑coaching programs, use of specialty‑drug rebate strategies (the presentation described a Cigna “save on SP” program that initially produced large savings), and expanded use of virtual physical‑therapy (a Hinge Health program) and chronic‑condition programs (Omada Complete). The consultants also noted specific line items the district already has or was offered: a 15% rate decrease on vision held for four years; a Mutual of Omaha hold on ancillary lines (life, AD&D, LTD) with a one‑year rate guarantee; and Delta Dental administration continuing at an unchanged admin fee of 10.56% of claims.

Committee discussion focused on the tradeoffs between richer benefit designs and cost containment. Staff said the district does not cover GLP‑1 weight‑loss medications today and that SchoolCare’s analysis showed few groups in the pool had elected to adopt coverage when it was offered with a 6% premium load. Consultants cautioned that if the district chooses to add coverage in the future, groups worry about the potential ongoing cost exposure and how to reverse coverage if needed. Presenters emphasized programs that pair medication with coaching and lifestyle supports to help preserve long‑term clinical benefit and limit downstream costs.

Staff noted the practical effect of prior policy changes: one set of earlier plan design and contribution changes has produced multi‑year savings that staff estimated at about $4.2 million relative to holding the older plan (a figure the presentation said translated to roughly a 6% impact on the tax rate). Committee members asked about employee communication and participation; staff said SchoolCare and Cigna use a mix of on‑site visits, virtual presentations, mailers, email and phone outreach to promote wellness programs and enrollment resources.

No formal board action was taken on the insurance renewal at the meeting. Presenters and staff said the renewal figures and recommended plan options will be incorporated into the district budget materials and returned to the committee for further review during the scheduled budget sessions.